Sue Siegel

Sue Siegel is an experienced leader and board member with a robust background in biochemistry and molecular biology, holding an MS from Boston University School of Medicine and a BSc from the University of Puerto Rico-Mayaguez. Currently serving on the boards of several prominent companies, including Align Technology, Illumina, Nevro, and The Engine, Sue Siegel also chairs the Compensation Committee at Illumina and leads the Investment & Finance Committee at KFF. Previously, Sue Siegel held significant roles at GE, where responsibilities included Chief Innovation Officer and CEO of GE Ventures. Additionally, Sue Siegel has held board positions at Pacific Biosciences, Corventis, and Crescendo Bioscience, demonstrating a strong commitment to governance and innovation in the biotechnology sector. Currently, Sue Siegel also serves as a Senior Lecturer at MIT Sloan School of Management.